Enlivex Therapeutics Stock Forecast

Hold candidate since Jul 09, 2026 Loss -7.30%

The Enlivex Therapeutics Ltd. stock price fell by -7.30% on the last day (Friday, 10th Jul 2026) from $7.40 to $6.86. During the last trading day the stock fluctuated 13.67% from a day low at $6.51 to a day high of $7.40. The price has fallen in 8 of the last 10 days and is down by -21.22% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 97 thousand shares were bought and sold for approximately $662.26 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $7.41 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.05% during the next 3 months and, with a 90% probability hold a price between $0.575 and $8.38 at the end of this 3-month period.

ENLV Signals & Forecast

The Enlivex Therapeutics Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.40 and $1.03. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -7.30%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Enlivex Therapeutics Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.89 between high and low, or 13.67%. For the last week the stock has had daily average volatility of 12.25%.

The Enlivex Therapeutics Ltd. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $6.50 (-5.18%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 91 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ENLV) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Enlivex Therapeutics Ltd. to open at $6.92, and during the day (based on 14 day Average True Range), to move between $6.45 and $7.27, which gives a possible trading interval of +/-$0.82 (+/-12.78%) up or down from last closing price. If Enlivex Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 12.78% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $7.21, some $0.347 (5.07%) from the current price of $6.86, our system finds the risk reward not very attractive.

Is Enlivex Therapeutics Ltd. stock A Buy?

Enlivex Therapeutics Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.897 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $6.92 ( 0.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk